Findings

What do systematic reviews say?

2,973 questions · 3,072 findings · 410 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 559 · 18.2%GRADE not reported 143 · 4.7%Very low 654 · 21.3%Low 833 · 27.1%Moderate 683 · 22.2%High 200 · 6.5%

Intervention not reported

False‐positives (patients incorrectly classified as having pleural TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 240 participants
Very low

Intervention not reported

Xpert MTB/RIF result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Xpert Ultra result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

True‐positives (patients with lymph node TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Intervention not reported

False‐negatives (patients incorrectly classified as not having lymph node TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

Intervention not reported

True‐negatives (patients without lymph node TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Very low

Intervention not reported

False‐positives (patients incorrectly classified as having lymph node TB)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
1 study · 43 participants
Very low

Intervention not reported

Xpert MTB/RIF result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Xpert Ultra result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

True‐positives (participants with TB meningitis)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 89 participants
Low

Intervention not reported

True‐positives (patients correctly classified as rifampicin resistant)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 24 participants
Low

Intervention not reported

False‐negatives (patients incorrectly classified as rifampicin susceptible)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 24 participants
Low

Intervention not reported

True‐negatives (patients correctly classified as rifampicin susceptible)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 105 participants
Moderate

Intervention not reported

False‐positives (patients incorrectly classified as rifampicin resistant)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 105 participants
Moderate

Intervention not reported

Xpert MTB/RIF result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

False‐negatives (participants incorrectly classified as not having TB meningitis)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 89 participants
Low

Intervention not reported

True‐negatives (participants without TB meningitis)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 386 participants
Moderate

Intervention not reported

False‐positives (participants incorrectly classified as having TB meningitis)

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
6 studies · 386 participants
Moderate

Intervention not reported

Xpert MTB/RIF result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Xpert Ultra result

The review found no eligible studies for this question.

1 finding from 1 review

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found